Lenvatinib inhibition of EMT in ICC cells

Lenvatinib enhanced AZGP1 activity through H3K27Ac modification and inhibited the downstream TGF-β1/Smad3 signaling pathway.
Lenvatinib inhibition of EMT in ICC cells

Publication

AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway (2023) Liming Deng, et al. Cell Death Dis. 2023 Sep;14(9):590. Figure: F7.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates AZGP1 AZGP1 ncbigene_symbol AZGP1 563
Homo sapiens Primates TGF-B1 TGF-B1 ncbigene_synonym TGFB1 7040
Homo sapiens Primates SMAD3 SMAD3 ncbigene_symbol SMAD3 4088
Homo sapiens Primates [E-cadherin] CDH1 ncbigene_symbol CDH1 999
Homo sapiens Primates [E-cadherin] CDH1 ncbigene_synonym FZR1 51343
Homo sapiens Primates [N-cadherin] CDH2 ncbigene_symbol CDH2 1000

Chemical mentions

Word Match MeSH Name ChEBI
Lenvatinib lenvatinib 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide chebi:85994
Lenvatinib lenvatinib 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide chebi:85994

Disease mentions

Word Match MeSH Name DOID